Safety of recombinant activated factor VII (rFVIIa) in patients with congenital haemophilia with inhibitors: overall rFVIIa exposure and intervals following high (>240 μg kg⁻¹) rFVIIa doses across clinical trials and registries.
| Image |  |
|---|---|
| Description | scientific article published in January 2014 |
| Author/s |
author: Ellis J Neufeld Victor S. Blanchette |
| Publication date | January 1, 2014 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |